Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ustekinumab yields sustained response in phase II and III trials in plaque psoriasis

Aug. 13, 2010

New models predict activity/selectivity of cannabinoid receptor agonists/antagonists

Aug. 11, 2010

Nabilone shows promise to treat cannabis use disorders

Aug. 10, 2010

Cannabidiol displays antiangiogenic activity in preclinical tests

Aug. 10, 2010

BPR-0912 exhibits antiobesity effects in vivo

Aug. 9, 2010

Preclinical study implicates GPR55 in regulation of osteoclast number and function

Aug. 6, 2010

Scientists explore neuroprotective role of URB-597 in models of retinal neurodegeneration

Aug. 6, 2010

PF-3845 has antiallodynic effects in preclinical study

Aug. 6, 2010

TM-38837 shows favorable safety and pharmacokinetics in healthy subjects

Aug. 5, 2010

Japanese scientists identify potential biomarkers for coronary artery disease

Aug. 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...